Literature DB >> 3028713

Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids.

A H Fagbami, S B Halstead, N J Marchette, K Larsen.   

Abstract

Cross-infection enhancement of seven African flaviviruses by subneutralising concentrations of antibody in immune ascitic fluids was investigated in P388D1 cell culture. Infection by all the seven flaviviruses tested was enhanced by homologous and at least one of six heterologous immune mouse ascitic fluids (IMAF) tested. Enhancement ratios and enhancing antibody titres were higher in homologous than in heterologous enhancement. Zika, Wesselsbron, Uganda S and West Nile viruses were enhanced in culture by all the IMAF tested. Enhancement of Dakar bat and Yellow fever viruses was produced by five heterologous IMAF, but Potiskum virus was enhanced by one heterologous flavivirus antibody. The antibody to Potiskum virus was the most potent mediator of heterologous infection enhancement; all six heterologous flaviviruses were markedly enhanced by this antibody.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3028713

Source DB:  PubMed          Journal:  Cytobios        ISSN： 0011-4529


  24 in total

Review 1.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

Review 2.  Assessing the global threat from Zika virus.

Authors:  Justin Lessler; Lelia H Chaisson; Lauren M Kucirka; Qifang Bi; Kyra Grantz; Henrik Salje; Andrea C Carcelen; Cassandra T Ott; Jeanne S Sheffield; Neil M Ferguson; Derek A T Cummings; C Jessica E Metcalf; Isabel Rodriguez-Barraquer
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

3.  A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Jenny C Cardenas; Alex Hall; Omar G Perez; Lucio Cardenas; Adam Hartstone-Rose; Scott B Halstead; Tonya M Colpitts
Journal:  J Gen Virol       Date:  2017-07-08       Impact factor: 3.891

Review 4.  Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.

Authors:  Daniela V Andrade; Eva Harris
Journal:  Virus Res       Date:  2017-06-26       Impact factor: 3.303

5.  Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.

Authors:  Priscila M S Castanha; Eduardo J M Nascimento; Cynthia Braga; Marli T Cordeiro; Otávio V de Carvalho; Leila R de Mendonça; Elisa A N Azevedo; Rafael F O França; Rafael Dhalia; Ernesto T A Marques
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

Review 6.  Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.

Authors:  Lalita Priyamvada; Mehul S Suthar; Rafi Ahmed; Jens Wrammert
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

Review 7.  The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Microbiol Mol Biol Rev       Date:  2017-02-08       Impact factor: 11.056

8.  Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses.

Authors:  Laura K Aisenberg; Kimberly E Rousseau; Katherine Cascino; Guido Massaccesi; William H Aisenberg; Wensheng Luo; Kar Muthumani; David B Weiner; Stephen S Whitehead; Michael A Chattergoon; Anna P Durbin; Andrea L Cox
Journal:  JCI Insight       Date:  2022-06-22

Review 9.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

Review 10.  Zika Virus: Medical Countermeasure Development Challenges.

Authors:  Robert W Malone; Jane Homan; Michael V Callahan; Jill Glasspool-Malone; Lambodhar Damodaran; Adriano De Bernardi Schneider; Rebecca Zimler; James Talton; Ronald R Cobb; Ivan Ruzic; Julie Smith-Gagen; Daniel Janies; James Wilson
Journal:  PLoS Negl Trop Dis       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.